Norifumi Kuratani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Norifumi Kuratani has a total of 87 co-authors. Here are the top co-authors by number of shared publications:
- Ekta Rai
Department of Anesthesia, Christian Medical College, Vellore, Tamil Nadu, India
3 shared publications - Hiroshi Hoshijima
Department of Anesthesiology, Saitama Medical University Hospital, 38 Morohongo, Moroyamacho Irumagun, Saitama 350-0495, Japan
3 shared publications - Toshiya Shiga
Department of Anesthesiology and Intensive Care Medicine, International University of Health and Welfare, School of Medicine, Ichikawa, Chiba 286-8686, Japan
3 shared publications - Andi Ade Wijaya Ramlan
Division of Pediatric Anesthesiology, Department of Anesthesiology and Intensive Care, Faculty of Medicine, Universitas Indonesia – Dr. Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia
2 shared publications - Choon Looi Bong
Department of Pediatric Anesthesia KK Women's and Children's Hospital Singapore Singapore
2 shared publications - David Cavanaugh
Boston Biostatistical Consulting, North Reading, MA 01864, USA
2 shared publications
Latest Publications
- 16 July 2026
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 137 (3) , 929-930
Impact of liberal preoperative clear fluid fasting regimens on the risk of pulmonary aspiration in children (EUROFAST). Comment on Br J Anaesth 2025; 135: 141–7
- 16 July 2026
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 137 (3) , 929-930
Impact of liberal preoperative clear fluid fasting regimens on the risk of pulmonary aspiration in children (EUROFAST). Comment on Br J Anaesth 2025; 135: 141–7
- 8 July 2026
- Published by Wiley in Pediatric Anesthesia
- Vol. 36 (10) , 1266-1273
Implementing the Safer Anaesthesia From Education Paediatrics Course in Japan: Contextual Adaptation and Early National Dissemination
Background: In Japan, declining birth rates and concentration of pediatric cases in fewer high‐volume children's hospitals have reduced anesthesiologists' opportunities, particularly during training, to gain experience in pediatric anesthesia. There is no standardized national curriculum, and training relies largely on workplace‐based learning. The Safer Anaesthesia From Education (SAFE) Paediatrics Course is a structured program originally developed for low‐ and middle‐income countries; whether it can be contextually adapted and disseminated in a high‐income country facing different training challenges has not been established. Aims: To describe the translation, contextual adaptation, early implementation, and initial national dissemination of the SAFE Paediatrics Course in Japan, including preliminary educational outcomes from a single‐center resident training program. Methods: We conducted a two‐phase descriptive educational project. Phase 1 comprised course translation, contextual adaptation, pilot testing of a multiple‐choice question (MCQ) examination, and pilot delivery. Phase 2 comprised single‐center implementation and evaluation at Saitama Children's Medical Center among anesthesia residents (October 2021–March 2023). Participants completed pre‐ and post‐course MCQ tests and confidence ratings; a post‐course survey assessed satisfaction. National dissemination was described using aggregated course‐level data. Results: Thirty residents participated in the single‐center evaluation. MCQ scores increased from 37.87 to 41.67 out of 50 (mean increase 3.80; 95% CI: 2.64–4.96; p < 0.001), and self‐rated confidence increased. Satisfaction was high (17/20 respondents rated the course 4 or 5). Between October 2021 and January 2026, 28 courses were delivered across four geographical areas and national meeting‐affiliated sessions, accounting for 359 participant attendances; many used condensed one‐day or half‐day formats. Conclusions: The SAFE Paediatrics Course was translated, contextually adapted, and implemented in Japan, with early dissemination across multiple geographical areas and flexible delivery formats. Preliminary single‐center outcomes support its suitability as a structured pediatric anesthesia educational program in this setting. Further multicenter and longitudinal evaluation is warranted.
- 8 July 2026
- Published by Wiley in Pediatric Anesthesia
- Vol. 36 (10) , 1266-1273
Implementing the Safer Anaesthesia From Education Paediatrics Course in Japan: Contextual Adaptation and Early National Dissemination
Background: In Japan, declining birth rates and concentration of pediatric cases in fewer high‐volume children's hospitals have reduced anesthesiologists' opportunities, particularly during training, to gain experience in pediatric anesthesia. There is no standardized national curriculum, and training relies largely on workplace‐based learning. The Safer Anaesthesia From Education (SAFE) Paediatrics Course is a structured program originally developed for low‐ and middle‐income countries; whether it can be contextually adapted and disseminated in a high‐income country facing different training challenges has not been established. Aims: To describe the translation, contextual adaptation, early implementation, and initial national dissemination of the SAFE Paediatrics Course in Japan, including preliminary educational outcomes from a single‐center resident training program. Methods: We conducted a two‐phase descriptive educational project. Phase 1 comprised course translation, contextual adaptation, pilot testing of a multiple‐choice question (MCQ) examination, and pilot delivery. Phase 2 comprised single‐center implementation and evaluation at Saitama Children's Medical Center among anesthesia residents (October 2021–March 2023). Participants completed pre‐ and post‐course MCQ tests and confidence ratings; a post‐course survey assessed satisfaction. National dissemination was described using aggregated course‐level data. Results: Thirty residents participated in the single‐center evaluation. MCQ scores increased from 37.87 to 41.67 out of 50 (mean increase 3.80; 95% CI: 2.64–4.96; p < 0.001), and self‐rated confidence increased. Satisfaction was high (17/20 respondents rated the course 4 or 5). Between October 2021 and January 2026, 28 courses were delivered across four geographical areas and national meeting‐affiliated sessions, accounting for 359 participant attendances; many used condensed one‐day or half‐day formats. Conclusions: The SAFE Paediatrics Course was translated, contextually adapted, and implemented in Japan, with early dissemination across multiple geographical areas and flexible delivery formats. Preliminary single‐center outcomes support its suitability as a structured pediatric anesthesia educational program in this setting. Further multicenter and longitudinal evaluation is warranted.
- 13 April 2026
- Published by Springer Nature in European Radiology
- Vol. 36 (8) , 6862-6863
Letter to the Editor: Neonatal airway ultrasound, useful reference, limited guidance for anesthesiologists
- 13 April 2026
- Published by Springer Nature in European Radiology
- Vol. 36 (8) , 6862-6863
Letter to the Editor: Neonatal airway ultrasound, useful reference, limited guidance for anesthesiologists
- 2 August 2025
- Published by Wiley in Pediatric Anesthesia
Development of the Japanese Version of the Modified Yale Preoperative Anxiety Scale (mYPAS) in Pediatric Anesthesia: A Pilot Study for Psychometric Evaluation
Background: Preoperative anxiety in children can lead to enduring psychological effects, highlighting the need for validated assessment tools. Although the modified Yale Preoperative Anxiety Scale is internationally recognized for evaluating pediatric anxiety, no validated Japanese version is available.Aims: We aimed to develop a Japanese version of the modified Yale Preoperative Anxiety Scale per internationally recognized translation guidelines, and conduct a pilot study to assess its feasibility, psychometric properties, and sample size requirements for future formal psychometric evaluations.Methods: After obtaining approval from the original authors, a translation team followed the International Society for Pharmacoeconomics and Outcomes Research Task Force Guidelines, including forward and back translations, cultural adaptation, and cognitive debriefing. This pilot study involved 15 children (aged 5–12 years) undergoing elective surgery under general anesthesia. Reliability (internal consistency, inter‐rater, and intra‐rater) and validity (concurrent validity against the State–Trait Anxiety Inventory for Children) were assessed. The Walter's formula was used to calculate the sample size needed for formal reliability studies.Results: Following a successful translation and cultural adaptation process, the Japanese version of the scale demonstrated high internal consistency (Cronbach's α = 0.954) and moderate‐to‐very‐good inter‐rater reliability (weighted Kappa = 0.42–0.92). Intra‐rater reliability was excellent (intraclass correlation coefficient = 0.86–0.97). However, correlations with the STAIC‐State were poor (rs = −0.20 to −0.01), likely reflecting cultural norms of emotional restraint and differences in assessment timings. Sample size calculations indicated that 99 patients would be required for future reliability studies.Conclusions: The Japanese version of the scale was successfully developed, and pilot findings indicated its feasibility in Japanese clinical settings; a large multicenter validation is now required to confirm its psychometric properties. Incorporating the developed version of the scale into clinical practice may facilitate earlier identification and management of pediatric preoperative anxiety in Japan.Trial Registration: UMIN Clinical Trials Registry: UMIN000047537
- 2 August 2025
- Published by Wiley in Pediatric Anesthesia
Development of the Japanese Version of the Modified Yale Preoperative Anxiety Scale (mYPAS) in Pediatric Anesthesia: A Pilot Study for Psychometric Evaluation
Background: Preoperative anxiety in children can lead to enduring psychological effects, highlighting the need for validated assessment tools. Although the modified Yale Preoperative Anxiety Scale is internationally recognized for evaluating pediatric anxiety, no validated Japanese version is available.Aims: We aimed to develop a Japanese version of the modified Yale Preoperative Anxiety Scale per internationally recognized translation guidelines, and conduct a pilot study to assess its feasibility, psychometric properties, and sample size requirements for future formal psychometric evaluations.Methods: After obtaining approval from the original authors, a translation team followed the International Society for Pharmacoeconomics and Outcomes Research Task Force Guidelines, including forward and back translations, cultural adaptation, and cognitive debriefing. This pilot study involved 15 children (aged 5–12 years) undergoing elective surgery under general anesthesia. Reliability (internal consistency, inter‐rater, and intra‐rater) and validity (concurrent validity against the State–Trait Anxiety Inventory for Children) were assessed. The Walter's formula was used to calculate the sample size needed for formal reliability studies.Results: Following a successful translation and cultural adaptation process, the Japanese version of the scale demonstrated high internal consistency (Cronbach's α = 0.954) and moderate‐to‐very‐good inter‐rater reliability (weighted Kappa = 0.42–0.92). Intra‐rater reliability was excellent (intraclass correlation coefficient = 0.86–0.97). However, correlations with the STAIC‐State were poor (rs = −0.20 to −0.01), likely reflecting cultural norms of emotional restraint and differences in assessment timings. Sample size calculations indicated that 99 patients would be required for future reliability studies.Conclusions: The Japanese version of the scale was successfully developed, and pilot findings indicated its feasibility in Japanese clinical settings; a large multicenter validation is now required to confirm its psychometric properties. Incorporating the developed version of the scale into clinical practice may facilitate earlier identification and management of pediatric preoperative anxiety in Japan.Trial Registration: UMIN Clinical Trials Registry: UMIN000047537
- Open Access
- 7 July 2025
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 143 (4) , 835-850
Adverse Events Associated with Airway Management in Pediatric Anesthesia: A Prospective, Multicenter, Observational Japan Pediatric Difficult Airway in Anesthesia (J-PEDIA) Study
Background: The incidence of adverse events and desaturation during airway-securing procedures (a sequence from preoxygenation to completion of tracheal intubation or supraglottic airway placement) under general anesthesia in children remains underexplored. Thus, this study investigated the incidence of adverse and desaturation events and associated risk factors. Methods: This was a prospective, multicenter, observational study conducted between June 2022 and January 2024 in 10 tertiary care (6 pediatric and 4 university [mixed adult–pediatric]) hospitals in Japan. A standardized data collection system was applied through the recruited institutions to collect 95% or more of cases. The primary and secondary outcomes were adverse events and a 10% or greater drop in oxygen saturation (desaturation) associated with airway-securing procedures. Results: There were 17,007 airway management procedures in 16,695 children (mean ± SD age, 6.3 ± 4.8 yr). Any adverse events occurred in 346 of 17,007 (2.0%; 95% CI, 1.8 to 2.3) children, including 189 of 17,007 (1.1%; 0.96 to 1.3) respiratory adverse events. Desaturation occurred during 395 of 17,007 (2.3%; 2.1 to 2.6) procedures, with 66 of 308 (21.4%; 17.0 to 26.4) in neonates and 210 of 2,298 (9.1%; 8.0 to 10.4) in infants. Multilevel regression analysis showed younger age (adjusted odds ratio, 0.92; 95% CI, 0.90 to 0.95; P < 0.001), airway management in radiation diagnostic/therapy rooms (5.7, 1.64 to 19.9; P = 0.006), airway sensitivity (1.46, 1.09 to 1.94; P = 0.010), craniocervical surgery (1.41, 1.09 to 1.83; P = 0.009), and presence of one anatomical difficult airway feature (1.74, 1.02 to 2.95; P = 0.042) versus two or more anatomic difficult airway features (2.82, 1.21 to 6.6; P = 0.017) as risk factors of any adverse events. Supraglottic airway device usage at the first attempt (0.42, 0.288 to 0.62; P < 0.001) and muscle relaxant administration (0.62, 0.43 to 0.89; P = 0.009) showed beneficial effects. Conclusions: The Japan Pediatric Difficult Airway in Anesthesia (J-PEDIA) study demonstrated adverse event and desaturation incidences and the impact of clinically relevant risk factors during airway-securing procedures in Asian children. This study can help anesthesiologists to identify high-risk children and create a safe airway-securing strategy.
- 7 July 2025
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 143 (4) , 835-850
Open AccessAdverse Events Associated with Airway Management in Pediatric Anesthesia: A Prospective, Multicenter, Observational Japan Pediatric Difficult Airway in Anesthesia (J-PEDIA) Study
Background: The incidence of adverse events and desaturation during airway-securing procedures (a sequence from preoxygenation to completion of tracheal intubation or supraglottic airway placement) under general anesthesia in children remains underexplored. Thus, this study investigated the incidence of adverse and desaturation events and associated risk factors. Methods: This was a prospective, multicenter, observational study conducted between June 2022 and January 2024 in 10 tertiary care (6 pediatric and 4 university [mixed adult–pediatric]) hospitals in Japan. A standardized data collection system was applied through the recruited institutions to collect 95% or more of cases. The primary and secondary outcomes were adverse events and a 10% or greater drop in oxygen saturation (desaturation) associated with airway-securing procedures. Results: There were 17,007 airway management procedures in 16,695 children (mean ± SD age, 6.3 ± 4.8 yr). Any adverse events occurred in 346 of 17,007 (2.0%; 95% CI, 1.8 to 2.3) children, including 189 of 17,007 (1.1%; 0.96 to 1.3) respiratory adverse events. Desaturation occurred during 395 of 17,007 (2.3%; 2.1 to 2.6) procedures, with 66 of 308 (21.4%; 17.0 to 26.4) in neonates and 210 of 2,298 (9.1%; 8.0 to 10.4) in infants. Multilevel regression analysis showed younger age (adjusted odds ratio, 0.92; 95% CI, 0.90 to 0.95; P < 0.001), airway management in radiation diagnostic/therapy rooms (5.7, 1.64 to 19.9; P = 0.006), airway sensitivity (1.46, 1.09 to 1.94; P = 0.010), craniocervical surgery (1.41, 1.09 to 1.83; P = 0.009), and presence of one anatomical difficult airway feature (1.74, 1.02 to 2.95; P = 0.042) versus two or more anatomic difficult airway features (2.82, 1.21 to 6.6; P = 0.017) as risk factors of any adverse events. Supraglottic airway device usage at the first attempt (0.42, 0.288 to 0.62; P < 0.001) and muscle relaxant administration (0.62, 0.43 to 0.89; P = 0.009) showed beneficial effects. Conclusions: The Japan Pediatric Difficult Airway in Anesthesia (J-PEDIA) study demonstrated adverse event and desaturation incidences and the impact of clinically relevant risk factors during airway-securing procedures in Asian children. This study can help anesthesiologists to identify high-risk children and create a safe airway-securing strategy.
- Open Access
- 9 November 2024
- Published by Wiley in Pediatric Anesthesia
- Vol. 35 (2) , 125-139
Protocol development and feasibility of the PEACH in Asia study: A pilot study on PEri‐anesthetic morbidity in CHildren in Asia
Background: Comprehensive data on pediatric anesthesia outcomes, particularly severe critical events (SCEs), are scarce in Asia. This highlights the need for standardized research to assess anesthesia safety and quality in the diverse settings.Aims: The PEACH in Asia pilot study aimed to test the feasibility of a standardized protocol for investigating SCEs in anesthesia practices across Asia, evaluate the data acquisition processes, and determine the sample size for a main study.Methods: This multicenter pilot study involved ten institutions across nine Asian countries, including children from birth to 15 years undergoing diagnostic or surgical procedures. Data on SCEs were collected using standardized definitions. The study assessed the feasibility and estimated the sample size needed for the main study.Results: The pilot study enrolled 330 patients, with a SCE incidence of 12.4% (95% CI: 9.2–16.4%). Respiratory events were observed in 7.0% of cases, cardiovascular instability in 4.9%, and drug errors in 0.6%. Based on the SCE incidence observed in the pilot study, the estimated sample size required for the main study is at least 10 958 patients. The pilot study demonstrated the feasibility of the study protocol but identified several challenges, particularly in resource‐limited settings. These challenges included a significant burden associated with data collection, technical issues with electronic case report forms (e‐CRFs), variability in patient enrollment across institutions (ranging from 4 to 86 patients per site), and incomplete data acquisition (24.8% of height data and 9.7% of disposition data were missing).Conclusions: The PEACH in Asia pilot study successfully validated a protocol for investigating SCEs in pediatric anesthesia across Asia. Addressing the challenges identified in the pilot study will be crucial for generating robust data to improve pediatric anesthesia safety in the region. Key issues to address include improving data collection methods, resolving e‐CRF technical difficulties, and ensuring consistent institutional support.
- 9 November 2024
- Published by Wiley in Pediatric Anesthesia
- Vol. 35 (2) , 125-139
Open AccessProtocol development and feasibility of the PEACH in Asia study: A pilot study on PEri‐anesthetic morbidity in CHildren in Asia
Background: Comprehensive data on pediatric anesthesia outcomes, particularly severe critical events (SCEs), are scarce in Asia. This highlights the need for standardized research to assess anesthesia safety and quality in the diverse settings.Aims: The PEACH in Asia pilot study aimed to test the feasibility of a standardized protocol for investigating SCEs in anesthesia practices across Asia, evaluate the data acquisition processes, and determine the sample size for a main study.Methods: This multicenter pilot study involved ten institutions across nine Asian countries, including children from birth to 15 years undergoing diagnostic or surgical procedures. Data on SCEs were collected using standardized definitions. The study assessed the feasibility and estimated the sample size needed for the main study.Results: The pilot study enrolled 330 patients, with a SCE incidence of 12.4% (95% CI: 9.2–16.4%). Respiratory events were observed in 7.0% of cases, cardiovascular instability in 4.9%, and drug errors in 0.6%. Based on the SCE incidence observed in the pilot study, the estimated sample size required for the main study is at least 10 958 patients. The pilot study demonstrated the feasibility of the study protocol but identified several challenges, particularly in resource‐limited settings. These challenges included a significant burden associated with data collection, technical issues with electronic case report forms (e‐CRFs), variability in patient enrollment across institutions (ranging from 4 to 86 patients per site), and incomplete data acquisition (24.8% of height data and 9.7% of disposition data were missing).Conclusions: The PEACH in Asia pilot study successfully validated a protocol for investigating SCEs in pediatric anesthesia across Asia. Addressing the challenges identified in the pilot study will be crucial for generating robust data to improve pediatric anesthesia safety in the region. Key issues to address include improving data collection methods, resolving e‐CRF technical difficulties, and ensuring consistent institutional support.
- 12 March 2024
- Published by Wiley in Pediatric Anesthesia
- Vol. 34 (9) , 884-892
The role of collaboration in educating the global pediatric anesthesia workforce
An estimated 1.7 billion children and adolescents do not have access to safe and affordable surgical care, and the vast majority of these are located in low‐middle‐income countries (LMICs). Pediatric anesthesia, a specialized field that requires a diverse set of knowledge and skills, has seen various advancements over the years and has become well‐established in upper‐middle and high‐income countries. However, in LMICs, due to a multitude of factors including severe workforce shortages, this has not been the case. Collaborations play a vital role in increasing the capacity of pediatric anesthesiology educators and training the pediatric anesthesia workforce. These efforts directly increase access for children who require surgical intervention. Collaboration models can be operationalized through bidirectional knowledge sharing, training, resource allocation, research and innovation, quality improvement, networking, and advocacy. This article aims to highlight a few of these collaborative efforts. Specifically, the role that the World Federation of Societies of Anaesthesiologists, the Safer Anesthesia from Education program, the Asian Society of Pediatric Anaesthesiologists, Pediatric Anesthesia Training in Africa, the Paediatric Anaesthesia Network New Zealand, the Safe Pediatric Anesthesia Network and two WhatsApp™ groups (global ped anesthesia and the Pediatric Difficult Intubation Collaborative) have played in improving anesthesiology care for children.
- 12 March 2024
- Published by Wiley in Pediatric Anesthesia
- Vol. 34 (9) , 884-892
The role of collaboration in educating the global pediatric anesthesia workforce
An estimated 1.7 billion children and adolescents do not have access to safe and affordable surgical care, and the vast majority of these are located in low‐middle‐income countries (LMICs). Pediatric anesthesia, a specialized field that requires a diverse set of knowledge and skills, has seen various advancements over the years and has become well‐established in upper‐middle and high‐income countries. However, in LMICs, due to a multitude of factors including severe workforce shortages, this has not been the case. Collaborations play a vital role in increasing the capacity of pediatric anesthesiology educators and training the pediatric anesthesia workforce. These efforts directly increase access for children who require surgical intervention. Collaboration models can be operationalized through bidirectional knowledge sharing, training, resource allocation, research and innovation, quality improvement, networking, and advocacy. This article aims to highlight a few of these collaborative efforts. Specifically, the role that the World Federation of Societies of Anaesthesiologists, the Safer Anesthesia from Education program, the Asian Society of Pediatric Anaesthesiologists, Pediatric Anesthesia Training in Africa, the Paediatric Anaesthesia Network New Zealand, the Safe Pediatric Anesthesia Network and two WhatsApp™ groups (global ped anesthesia and the Pediatric Difficult Intubation Collaborative) have played in improving anesthesiology care for children.
- Open Access
- 29 November 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (11) , e0250909
Incidence of long-term post-acute sequelae of SARS-CoV-2 infection related to pain and other symptoms: A systematic review and meta-analysis
Background: Persistent symptoms are reported in patients who survive the initial stage of COVID-19, often referred to as “long COVID” or “post-acute sequelae of SARS-CoV-2 infection” (PASC); however, evidence on their incidence is still lacking, and symptoms relevant to pain are yet to be assessed. Methods: A literature search was performed using the electronic databases PubMed, EMBASE, Scopus, and CHINAL and preprint servers MedRχiv and BioRχiv through January 15, 2021. The primary outcome was pain-related symptoms such as headache or myalgia. Secondary outcomes were symptoms relevant to pain (depression or muscle weakness) and symptoms frequently reported (anosmia and dyspnea). Incidence rates of symptoms were pooled using inverse variance methods with a DerSimonian-Laird random-effects model. The source of heterogeneity was explored using meta-regression, with follow-up period, age and sex as covariates. Results: In total, 38 studies including 19,460 patients were eligible. Eight pain-related symptoms and 26 other symptoms were identified. The highest pooled incidence among pain-related symptoms was chest pain (17%, 95% confidence interval [CI], 11%-24%), followed by headache (16%, 95% CI, 9%-27%), arthralgia (13%, 95% CI, 7%-24%), neuralgia (12%, 95% CI, 3%-38%) and abdominal pain (11%, 95% CI, 7%-16%). The highest pooled incidence among other symptoms was fatigue (44%, 95% CI, 32%-57%), followed by insomnia (27%, 95% CI, 10%-55%), dyspnea (26%, 95% CI, 17%-38%), weakness (25%, 95% CI, 8%-56%) and anosmia (19%, 95% CI, 13%-27%). Substantial heterogeneity was identified (I2, 50–100%). Meta-regression analyses partially accounted for the source of heterogeneity, and yet, 53% of the symptoms remained unexplained. Conclusions: The current meta-analysis may provide a complete picture of incidence in PASC. It remains unclear, however, whether post-COVID symptoms progress or regress over time or to what extent PASC are associated with age or sex.
- 29 November 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (11) , e0250909
Open AccessIncidence of long-term post-acute sequelae of SARS-CoV-2 infection related to pain and other symptoms: A systematic review and meta-analysis
Background: Persistent symptoms are reported in patients who survive the initial stage of COVID-19, often referred to as “long COVID” or “post-acute sequelae of SARS-CoV-2 infection” (PASC); however, evidence on their incidence is still lacking, and symptoms relevant to pain are yet to be assessed. Methods: A literature search was performed using the electronic databases PubMed, EMBASE, Scopus, and CHINAL and preprint servers MedRχiv and BioRχiv through January 15, 2021. The primary outcome was pain-related symptoms such as headache or myalgia. Secondary outcomes were symptoms relevant to pain (depression or muscle weakness) and symptoms frequently reported (anosmia and dyspnea). Incidence rates of symptoms were pooled using inverse variance methods with a DerSimonian-Laird random-effects model. The source of heterogeneity was explored using meta-regression, with follow-up period, age and sex as covariates. Results: In total, 38 studies including 19,460 patients were eligible. Eight pain-related symptoms and 26 other symptoms were identified. The highest pooled incidence among pain-related symptoms was chest pain (17%, 95% confidence interval [CI], 11%-24%), followed by headache (16%, 95% CI, 9%-27%), arthralgia (13%, 95% CI, 7%-24%), neuralgia (12%, 95% CI, 3%-38%) and abdominal pain (11%, 95% CI, 7%-16%). The highest pooled incidence among other symptoms was fatigue (44%, 95% CI, 32%-57%), followed by insomnia (27%, 95% CI, 10%-55%), dyspnea (26%, 95% CI, 17%-38%), weakness (25%, 95% CI, 8%-56%) and anosmia (19%, 95% CI, 13%-27%). Substantial heterogeneity was identified (I2, 50–100%). Meta-regression analyses partially accounted for the source of heterogeneity, and yet, 53% of the symptoms remained unexplained. Conclusions: The current meta-analysis may provide a complete picture of incidence in PASC. It remains unclear, however, whether post-COVID symptoms progress or regress over time or to what extent PASC are associated with age or sex.
- Open Access
- 13 September 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (18) , 5937
Remimazolam for Pediatric Procedural Sedation: Results of an Institutional Pilot Program
Remimazolam, an ultra-short-acting benzodiazepine sedative, was first approved in 2020 in Japan as a general anesthetic for adults. However, its utilization in pediatric settings remains unexplored and, to date, is confined to isolated case reports due to a lack of specific pediatric labeling. The primary objective of our study was to evaluate the safety profile of remimazolam when used for procedural sedation in children following dosages established in adult protocols. Additional parameters, including dosage per kg of body weight, duration of the procedure, efficacy (measured as successful completion of the procedure), the necessity for supplemental medications, and changes in physiological parameters, such as the heart rate (HR) and mean arterial blood pressure (MAP), were assessed. Our study encompassed 48 children with an average age of 7.0 years. The objective Tracking and Reporting Outcomes of Procedural Sedation tool indicated no adverse events. In our cohort, propofol and ketamine were used as adjunctive treatments in 8 and 39 patients, respectively, with successful completion of all procedures. Notable hemodynamic variability was observed, with 88.4% of patients experiencing a ≥20% change (increase or decrease) and 62.8% experiencing a ≥30% change in MAP. Additionally, a ≥20% change in HR was observed in 54.3% of patients, and a ≥30% change was observed in 34.8% of patients. Nevertheless, none of the patients required pharmacological intervention to manage these hemodynamic fluctuations. Our findings suggest that remimazolam, when supplemented with propofol or ketamine, could offer a safe and effective pathway for administering procedural sedation in pediatric populations.
- 13 September 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (18) , 5937
Open AccessRemimazolam for Pediatric Procedural Sedation: Results of an Institutional Pilot Program
Remimazolam, an ultra-short-acting benzodiazepine sedative, was first approved in 2020 in Japan as a general anesthetic for adults. However, its utilization in pediatric settings remains unexplored and, to date, is confined to isolated case reports due to a lack of specific pediatric labeling. The primary objective of our study was to evaluate the safety profile of remimazolam when used for procedural sedation in children following dosages established in adult protocols. Additional parameters, including dosage per kg of body weight, duration of the procedure, efficacy (measured as successful completion of the procedure), the necessity for supplemental medications, and changes in physiological parameters, such as the heart rate (HR) and mean arterial blood pressure (MAP), were assessed. Our study encompassed 48 children with an average age of 7.0 years. The objective Tracking and Reporting Outcomes of Procedural Sedation tool indicated no adverse events. In our cohort, propofol and ketamine were used as adjunctive treatments in 8 and 39 patients, respectively, with successful completion of all procedures. Notable hemodynamic variability was observed, with 88.4% of patients experiencing a ≥20% change (increase or decrease) and 62.8% experiencing a ≥30% change in MAP. Additionally, a ≥20% change in HR was observed in 54.3% of patients, and a ≥30% change was observed in 34.8% of patients. Nevertheless, none of the patients required pharmacological intervention to manage these hemodynamic fluctuations. Our findings suggest that remimazolam, when supplemented with propofol or ketamine, could offer a safe and effective pathway for administering procedural sedation in pediatric populations.
- Open Access
- 8 June 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (12) , 3930
Remimazolam as an Adjunct to General Anesthesia in Children: Adverse Events and Outcomes in a Large Cohort of 418 Cases
Remimazolam was first approved in 2020 as a general anesthetic for adults and still does not have pediatric labeling. Our study will be the first pilot program that administers remimazolam as an adjunct to a general endotracheal anesthetic in children. Between August 2020 and December 2022, electronic medical records were collected for all children who received remimazolam during anesthesia. The remimazolam dosing regimen was extrapolated from the adult package insert, with intravenous induction doses of 12 mg/kg/h administered until the desired effect was achieved. Subsequent infusions were given at a rate of 1–2 mg/kg/h, accompanied by intermittent boluses of 0.2 mg/kg, with all dosing adjustments made according to the anesthesiologist’s clinical discretion. A total of 418 children (mean 4.6 yrs, 68.7% ASA 1 and 2) underwent surgeries which averaged 81.2 min. A total of 75.2% of patients had greater than a 20% change (increase or decrease) in MAP (lowest or highest) from baseline, and 203 (49.3%) patients had greater than a 30% change (increase or decrease) in MAP (lowest or highest) from baseline. A total of 5% received ephedrine to treat unanticipated hemodynamic variability. Discharge criteria were met within an average of 13.8 min after arrival at the post-anesthesia care unit. Remimazolam may offer the benefits of rapid recovery following general endotracheal anesthesia. The risk of hemodynamic variability which necessitates and responds to ephedrine should be anticipated.
- 8 June 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (12) , 3930
Open AccessRemimazolam as an Adjunct to General Anesthesia in Children: Adverse Events and Outcomes in a Large Cohort of 418 Cases
Remimazolam was first approved in 2020 as a general anesthetic for adults and still does not have pediatric labeling. Our study will be the first pilot program that administers remimazolam as an adjunct to a general endotracheal anesthetic in children. Between August 2020 and December 2022, electronic medical records were collected for all children who received remimazolam during anesthesia. The remimazolam dosing regimen was extrapolated from the adult package insert, with intravenous induction doses of 12 mg/kg/h administered until the desired effect was achieved. Subsequent infusions were given at a rate of 1–2 mg/kg/h, accompanied by intermittent boluses of 0.2 mg/kg, with all dosing adjustments made according to the anesthesiologist’s clinical discretion. A total of 418 children (mean 4.6 yrs, 68.7% ASA 1 and 2) underwent surgeries which averaged 81.2 min. A total of 75.2% of patients had greater than a 20% change (increase or decrease) in MAP (lowest or highest) from baseline, and 203 (49.3%) patients had greater than a 30% change (increase or decrease) in MAP (lowest or highest) from baseline. A total of 5% received ephedrine to treat unanticipated hemodynamic variability. Discharge criteria were met within an average of 13.8 min after arrival at the post-anesthesia care unit. Remimazolam may offer the benefits of rapid recovery following general endotracheal anesthesia. The risk of hemodynamic variability which necessitates and responds to ephedrine should be anticipated.